Esperion Therapeutics | ESPR - Trade Debtors


Esperion Therapeutics reported $140.19M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.59B 180M Dec/2025
Alnylam Pharmaceuticals USD 883.96M 106.39M Mar/2026
Alterity Therapeutics Limited AUD 4.57M 1.42M Dec/2025
Amarin USD 126.83M 477K Dec/2025
Amgen USD 9.14B 432M Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
BioMarin Pharmaceutical USD 903.91M 4.3M Mar/2026
Cipla INR 62.19B 12.42B Mar/2026
CSL USD 4.32B 1.35B Dec/2025
Cytokinetics USD 6.83M 10.94M Mar/2026
Daiichi Sankyo JPY 695.95B 79.1B Dec/2025
Eli Lilly USD 21.18B 1.02B Mar/2026
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
Geron USD 39.23M 1.57M Dec/2025
Grifols EUR 1B 285.88M Dec/2025
Halozyme Therapeutics USD 457.99M 16.72M Mar/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Ionis Pharmaceuticals USD 74M 8M Mar/2026
Merck USD 11.78B 345M Dec/2025
Moderna USD 71M 113M Mar/2026
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Pfizer USD 16.17B 332M Mar/2026
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Sanofi EUR 482M 85M Mar/2026
Sarepta Therapeutics USD 547.91M 149.68M Mar/2026
United Therapeutics USD 312M 38.2M Mar/2026
Vanda Pharmaceuticals USD 47.1M 4.35M Dec/2024